{"pmid":32336303,"title":"Risk factors for serious/critical COVID-19 illness in health care workers: Too many unknowns.","text":["Risk factors for serious/critical COVID-19 illness in health care workers: Too many unknowns.","Infect Control Hosp Epidemiol","Wander, Pandora L","Orlov, Marika","Merel, Susan E","Enquobahrie, Daniel A","32336303"],"journal":"Infect Control Hosp Epidemiol","authors":["Wander, Pandora L","Orlov, Marika","Merel, Susan E","Enquobahrie, Daniel A"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32336303","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1017/ice.2020.178","topics":["Prevention"],"weight":1,"_version_":1665264685547520000,"score":8.574329,"similar":[{"pmid":32327314,"title":"COVID-19, mobile health and serious mental illness.","text":["COVID-19, mobile health and serious mental illness.","Schizophr Res","Torous, John","Keshavan, Matcheri","32327314"],"journal":"Schizophr Res","authors":["Torous, John","Keshavan, Matcheri"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32327314","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.schres.2020.04.013","source":"PubMed","weight":0,"_version_":1664996914770214913,"score":78.8358},{"pmid":32292901,"pmcid":"PMC7142689","title":"Pathogenic Priming Likely Contributes to Serious and Critical Illness and Mortality in COVID-19 via Autoimmunity.","text":["Pathogenic Priming Likely Contributes to Serious and Critical Illness and Mortality in COVID-19 via Autoimmunity.","Homology between human and viral proteins is an established factor in viral- or vaccine-induced autoimmunity. Failure of SARS and MERS vaccines in animal trials involved pathogenesis consistent with an immunological priming that could involve autoimmunity in lung tissues due to previous exposure to the SARS and MERS spike protein. Exposure pathogenesis to SARS-CoV-2 in COVID-19 likely will lead to similar outcomes. Immunogenic peptides in viruses or bacteria that match human proteins are good candidates for pathogenic priming peptides (similar to the more diffuse idea of \"immune enhancement\"). Here I provide an assessment of potential for human pathogenesis via autoimmunity via exposure, via infection or injection. SAR-CoV-2 spike proteins, and all other SARS-CoV-2 proteins, immunogenic epitopes in each SARS-CoV-2 protein were compared to human proteins in search of high local homologous matching. Only one immunogenic epitope in a SARS-CoV-2 had no homology to human proteins. If all of the parts of the epitopes that are homologous to human proteins are excluded from consideration due to risk of pathogenic priming, the remaining immunogenic parts of the epitopes may be still immunogenic and remain as potentially viable candidates for vaccine development. Mapping of the genes encoding human protein matches to pathways point to targets that could explain the observed presentation of symptoms in COVID-19 disease. It also strongly points to a large number of opportunities for expected disturbances in the immune system itself, targeting elements of MCH Class I and Class II antigen presentation, PD-1 signaling, cross-presentation of soluble exogenous antigens and the ER-Phagosome pathway. Translational consequences of these findings are explored.","J Transl Autoimmun","Lyons-Weiler, James","32292901"],"abstract":["Homology between human and viral proteins is an established factor in viral- or vaccine-induced autoimmunity. Failure of SARS and MERS vaccines in animal trials involved pathogenesis consistent with an immunological priming that could involve autoimmunity in lung tissues due to previous exposure to the SARS and MERS spike protein. Exposure pathogenesis to SARS-CoV-2 in COVID-19 likely will lead to similar outcomes. Immunogenic peptides in viruses or bacteria that match human proteins are good candidates for pathogenic priming peptides (similar to the more diffuse idea of \"immune enhancement\"). Here I provide an assessment of potential for human pathogenesis via autoimmunity via exposure, via infection or injection. SAR-CoV-2 spike proteins, and all other SARS-CoV-2 proteins, immunogenic epitopes in each SARS-CoV-2 protein were compared to human proteins in search of high local homologous matching. Only one immunogenic epitope in a SARS-CoV-2 had no homology to human proteins. If all of the parts of the epitopes that are homologous to human proteins are excluded from consideration due to risk of pathogenic priming, the remaining immunogenic parts of the epitopes may be still immunogenic and remain as potentially viable candidates for vaccine development. Mapping of the genes encoding human protein matches to pathways point to targets that could explain the observed presentation of symptoms in COVID-19 disease. It also strongly points to a large number of opportunities for expected disturbances in the immune system itself, targeting elements of MCH Class I and Class II antigen presentation, PD-1 signaling, cross-presentation of soluble exogenous antigens and the ER-Phagosome pathway. Translational consequences of these findings are explored."],"journal":"J Transl Autoimmun","authors":["Lyons-Weiler, James"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292901","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jtauto.2020.100051","keywords":["autoimmunity","covid-19","immuneenhancement","pathogenic priming","sars-cov-2"],"source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1664636192716488704,"score":72.341606},{"pmid":32242888,"title":"Addressing the COVID-19 Pandemic in Populations With Serious Mental Illness.","text":["Addressing the COVID-19 Pandemic in Populations With Serious Mental Illness.","JAMA Psychiatry","Druss, Benjamin G","32242888"],"journal":"JAMA Psychiatry","authors":["Druss, Benjamin G"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32242888","week":"202014|Mar 30 - Apr 05","doi":"10.1001/jamapsychiatry.2020.0894","source":"PubMed","weight":0,"_version_":1664638249380872192,"score":66.12592},{"pmid":32247898,"title":"Unknown unknowns - COVID-19 and potential global mortality.","text":["Unknown unknowns - COVID-19 and potential global mortality.","COVID-19 (SARS-CoV-2) is currently a global pandemic. This paper will attempt to estimate global infection rates and potential resultant mortality in the absence of effective treatment and/or vaccination. Calculations are based on World Health Organisation data from Wuhan in China: 14% of infected cases are severe, 5% require intensive care and 4% die. Estimated infection rates and mortality rates at the level of continents and some individual countries (when these are of sufficient size) are tabulated. This pandemic may cause close to half a billion deaths, i.e. 6% of the global population - and potentially more. At the risk of sounding sensational, but with a sober sense of realism, healthcare risks being plunged into the Middle-Ages if the public do not do their part. Infection cannot occur in the absence of contact. The only way to mitigate these numbers is to apply social distancing and take the standard precautions so frequently reiterated by Public Health: hand washing, avoid touching the face and so on. These measures are crucial as the human cost is going to be unthinkable even in the best-case scenarios that epidemiologists are modelling.","Early Hum Dev","Grech, Victor","32247898"],"abstract":["COVID-19 (SARS-CoV-2) is currently a global pandemic. This paper will attempt to estimate global infection rates and potential resultant mortality in the absence of effective treatment and/or vaccination. Calculations are based on World Health Organisation data from Wuhan in China: 14% of infected cases are severe, 5% require intensive care and 4% die. Estimated infection rates and mortality rates at the level of continents and some individual countries (when these are of sufficient size) are tabulated. This pandemic may cause close to half a billion deaths, i.e. 6% of the global population - and potentially more. At the risk of sounding sensational, but with a sober sense of realism, healthcare risks being plunged into the Middle-Ages if the public do not do their part. Infection cannot occur in the absence of contact. The only way to mitigate these numbers is to apply social distancing and take the standard precautions so frequently reiterated by Public Health: hand washing, avoid touching the face and so on. These measures are crucial as the human cost is going to be unthinkable even in the best-case scenarios that epidemiologists are modelling."],"journal":"Early Hum Dev","authors":["Grech, Victor"],"date":"2020-04-06T11:00:00Z","year":2020,"_id":"32247898","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.earlhumdev.2020.105026","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664637850777288704,"score":62.513996},{"pmid":32287787,"pmcid":"PMC7131653","title":"Deadly unknowns.","text":["Deadly unknowns.","We are still scrambling to understand how dangerous the Wuhan coronavirus is.","New Sci","32287787"],"abstract":["We are still scrambling to understand how dangerous the Wuhan coronavirus is."],"journal":"New Sci","date":"2020-04-15T11:00:00Z","year":2020,"_id":"32287787","week":"202016|Apr 13 - Apr 19","doi":"10.1016/S0262-4079(20)30233-5","source":"PubMed","topics":["General Info"],"weight":1,"locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664636391694270464,"score":55.5961}]}